BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Ikena Oncology, Inc. (IKNA)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Ikena Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:22 pm
Sale		 2024-12-31 13G Ikena Oncology, Inc.
IKNA		 BIOTECHNOLOGY VALUE FUND L P 4,006,564
8.300%		 -762,600decrease
(-15.99%)		 Filing
2024-02-14
09:47 am
Purchase		 2023-12-31 13G Ikena Oncology, Inc.
IKNA		 BIOTECHNOLOGY VALUE FUND L P 4,769,164
9.900%		 2,266,093increase
(+90.53%)		 Filing
2023-02-13
6:11 pm
Purchase		 2022-12-31 13G Ikena Oncology, Inc.
IKNA		 BIOTECHNOLOGY VALUE FUND L P 2,503,071
6.900%		 704,700increase
(+39.19%)		 Filing
2022-02-14
1:35 pm
Purchase		 2021-12-31 13G Ikena Oncology, Inc.
IKNA		 BIOTECHNOLOGY VALUE FUND L P 1,798,371
5.000%		 198,713increase
(+12.42%)		 Filing
2021-04-05
5:03 pm
Purchase		 2021-03-26 13G Ikena Oncology, Inc.
IKNA		 BIOTECHNOLOGY VALUE FUND L P 1,599,658
5.100%		 1,599,658increase
(New Position)		 Filing